Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported):  June 20, 2024 Balchem Corporation (Exact name of registrant as specified in its charter) Maryland 1-13648 13-2578432 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 5 Paragon Drive , Montvale , NJ 07645 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 845 ) 326-5600 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered   Common Stock, par value $.06-2/3 per share   BCPC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07 - Submission of Matters to a Vote of Security Holders   Balchem Corporation (the “Company”) held its Annual Meeting of Shareholders on June 20, 2024. Set forth below is information regarding the results of the matters voted on by shareholders at the Annual Meeting:   1.          The e lection of four Class 2 director nominees to the Board of Directors to serve until the Annual Meeting of Shareholders in 2027 or until their successors are duly elected and qualified :     Director Nominee   Votes For   Votes Against   Abstained   Broker Non-Votes   Daniel Knutson   27,420,722   534,637   11,582   1,555,476   Joyce Lee   23,968,891   3,987,153   10,897   1,555,476   Olivier Rigaud   24,601,193   3,350,287   15,461   1,555,476   Monica Vicente   27,844,683   111,268   10,990   1,555,476 2.          The ratification of the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024:     Votes For   Votes Against   Abstained   28,981,040   536,045   5,332  3.         Advisory approval of the compensation of the Company’s named executive officers:     Votes For   Votes Against   Abstained   Broker Non-Votes   27,117,930   813,592   35,419   1,555,476 SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   BALCHEM CORPORATION       By:/s/ Hatsuki Miyata   Hatsuki Miyata, General Counsel and Secretary Dated: June 24, 2024